Phase II Study of Nab-Paclitaxel in Refractory Small Bowel Adenocarcinoma and CpG Island Methylator Phenotype (CIMP)-high Colorectal Cancer

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdy221
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy